People: MedAssets Inc (MDAS.OQ)

MDAS.OQ on NASDAQ Stock Exchange Global Select Market

21.19USD
4:00pm EDT
Price Change (% chg)

$-0.04 (-0.19%)
Prev Close
$21.23
Open
$21.12
Day's High
$21.29
Day's Low
$20.89
Volume
139,605
Avg. Vol
230,065
52-wk High
$26.58
52-wk Low
$19.38

Search Stocks

Wesson, Bruce 

Brief Biography

Mr. Bruce F. Wesson is Lead Independent Vice Chairman of the Board of MedAssets Inc. Mr. Wesson is a founding director of the Company and currently serves as Lead Director and Vice-Chairman of our Board of Directors, Chairman of the Audit Committee and as a member of the Information Technology Committee of the Board of Directors. Mr. Wesson is Founding Partner Emeritus and Senior Advisor at Galen Management, a healthcare venture firm, after serving as Managing Director from 1990 to 2011 as well as general partner of Galen Partners, L.P. over the same period. Mr. Wesson served over twenty-three years with the Corporate Finance Division of Smith Barney, Harris Upham & Co. Inc. (“Smith Barney”), an investment banking firm, most recently as Senior Vice President and Managing Director. While at Smith Barney, Mr. Wesson headed the “Major Account Group”, which was responsible for many of the firm’s largest accounts. He also chaired the Valuation Committee, which supervised all valuation opinions provided by the firm. Mr. Wesson served as a director of Chemtura Corporation from 1980 to 2010. Mr. Wesson serves as a Director and as a member of the Compensation and Audit Committees of Acura Pharmaceuticals, Inc., a specialty pharmaceutical company. In addition, Mr. Wesson has served as a Director (since 2006), including as Vice Lead Director (since 2008) and on the Compensation Committee of Derma Sciences, Inc., a manufacturer of dermatological products and also serves on the Board of Directors for several privately held companies. Mr. Wesson holds a B.A. from Colgate University and a M.B.A. from Columbia Graduate Business School. Mr. Wesson’s experience as Senior Vice President and Managing Director of Smith Barney’s Corporate Finance Department and as the founder of Galen Partners, a health care private equity firm, brings to the Board extensive knowledge of the capital markets and corporate finance, as well as entrepreneurial experience.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Bardis

2,971,380

Terrence Mulligan

--

Bruce Wesson

--

Charles Garner

1,051,520

Amy Amick

--

Keith Thurgood

1,148,630
As Of 30 Dec 2013
Search Stocks